Moderna announced it is investing in a new science centre, known as the Moderna Science Center, at 325 Binney Street in Cambridge, Massachusetts to create a purpose-built space to support the Company’s next chapter of discovery.

“We have been located in Massachusetts since our founding more than 10 years ago and are proud to be based here. As we advance our mRNA platform and science, our new science centre will integrate digital-first scientific research and development labs along with space for innovation and co-creation with our people and our partners around the world,” said Stéphane Bancel, Chief Executive Officer of Moderna.

The environmentally sustainable, digitally-enabled 462,000 square foot Moderna Science centre is being built to support Moderna’s growth as the company continues to advance its pipeline of mRNA medicines. The new site will include custom spaces for leading-edge research and development. The building will integrate scientific and non-scientific spaces to maximise collaboration and provoke disruptive innovation. Construction at the location has begun and the company expects to begin a phased move-in process in 2023.

As part of Moderna’s commitment to sustainability, the high-performance building is targeting LEED Platinum Core & Shell and LEED Zero Energy certifications and is designed to be the most sustainable commercial lab building in Cambridge. To achieve this, the building will include ultra-efficient systems and acoustical and light pollution mitigation measures.

Since its founding in 2010, Moderna has been based in the East Cambridge life sciences hub in Massachusetts. The Company opened its manufacturing facility in Norwood, Massachusetts in 2018 and recently announced an investment and expansion in Norwood, including a more than doubling of space to transform the facility from a production and lab space to an industrial technology centre. Today, Moderna has 37 programs in development, including 22 in ongoing clinical studies.